CH661436A5 - Compositions de nifedipine administrables par voie rectale et procedes pour leur fabrication. - Google Patents
Compositions de nifedipine administrables par voie rectale et procedes pour leur fabrication. Download PDFInfo
- Publication number
- CH661436A5 CH661436A5 CH5421/84A CH542184A CH661436A5 CH 661436 A5 CH661436 A5 CH 661436A5 CH 5421/84 A CH5421/84 A CH 5421/84A CH 542184 A CH542184 A CH 542184A CH 661436 A5 CH661436 A5 CH 661436A5
- Authority
- CH
- Switzerland
- Prior art keywords
- nifedipine
- oil
- weight
- fat
- parts
- Prior art date
Links
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 title claims description 60
- 229960001597 nifedipine Drugs 0.000 title claims description 60
- 239000000203 mixture Substances 0.000 title claims description 26
- 238000000034 method Methods 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 4
- 239000008240 homogeneous mixture Substances 0.000 claims 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 2
- 239000000829 suppository Substances 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 16
- 229920001223 polyethylene glycol Polymers 0.000 description 15
- 239000002202 Polyethylene glycol Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- -1 there 1 Chemical compound 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/15—Suppositories
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58217396A JPS60109519A (ja) | 1983-11-17 | 1983-11-17 | ニフェジピン坐剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH661436A5 true CH661436A5 (fr) | 1987-07-31 |
Family
ID=16703529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5421/84A CH661436A5 (fr) | 1983-11-17 | 1984-11-13 | Compositions de nifedipine administrables par voie rectale et procedes pour leur fabrication. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4874774A (enExample) |
| JP (1) | JPS60109519A (enExample) |
| KR (1) | KR920001459B1 (enExample) |
| CA (1) | CA1238279A (enExample) |
| CH (1) | CH661436A5 (enExample) |
| DE (1) | DE3442065C2 (enExample) |
| ES (1) | ES537705A0 (enExample) |
| FR (1) | FR2555048B1 (enExample) |
| GB (1) | GB2149662B (enExample) |
| IT (1) | IT1178239B (enExample) |
| NL (1) | NL8403310A (enExample) |
| SE (1) | SE464742B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2736269B2 (ja) * | 1989-07-20 | 1998-04-02 | 日清製粉株式会社 | １，４−ジヒドロピリジン医薬組成物 |
| US5145859A (en) * | 1991-03-20 | 1992-09-08 | Case Western Reserve University | Methods of treating interstitial cystitis and urethral syndrome |
| JP3467628B2 (ja) * | 1991-05-24 | 2003-11-17 | 岩城製薬株式会社 | 坐剤用基剤 |
| ES2224362T3 (es) | 1997-02-24 | 2005-03-01 | S.L.A. Pharma Ag | Composicon farmaceutica topica que comprende un agente colinergico o un bloqueador del canal del calcio. |
| US6537504B1 (en) | 1998-04-06 | 2003-03-25 | Li Young | Method and apparatus for concurrent and sequential multi-step reactions for producing a plurality of different chemical compounds |
| DE19949897A1 (de) * | 1999-10-15 | 2001-04-19 | Rainer Rogasch | Formkörper und Verfahren zu dessen Herstellung |
| RU2177781C1 (ru) * | 2000-12-06 | 2002-01-10 | Научный Центр Здоровья детей РАМН | Суппозитории ректальные, содержащие витаминный комплекс |
| ITMI20020756A1 (it) * | 2002-04-09 | 2003-10-09 | Sinclair Pharma S R L | Composizioni farmaceutiche topiche per il trattamento delle dermatiti |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2538127A (en) * | 1948-02-26 | 1951-01-16 | Searle & Co | Medicated suppositories and bases therefor |
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| JPS6030650B2 (ja) * | 1979-10-26 | 1985-07-17 | 日本油脂株式会社 | 座薬基剤組成物 |
| JPS56115726A (en) * | 1980-02-20 | 1981-09-11 | Kaken Pharmaceut Co Ltd | Pharmaceutical containing nifedipine |
| DE3021958A1 (de) * | 1980-06-12 | 1981-12-24 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel |
| JPS5758609A (en) * | 1980-09-26 | 1982-04-08 | Kaken Pharmaceut Co Ltd | Drug containing nifedipine |
| DE3241263A1 (de) * | 1982-11-09 | 1984-05-10 | Troponwerke GmbH & Co KG, 5000 Köln | Indometacin enthaltende rektale zubereitungen |
-
1983
- 1983-11-17 JP JP58217396A patent/JPS60109519A/ja active Granted
-
1984
- 1984-10-19 GB GB08426420A patent/GB2149662B/en not_active Expired
- 1984-10-31 NL NL8403310A patent/NL8403310A/nl not_active Application Discontinuation
- 1984-11-13 CH CH5421/84A patent/CH661436A5/fr not_active IP Right Cessation
- 1984-11-15 KR KR1019840007171A patent/KR920001459B1/ko not_active Expired
- 1984-11-15 SE SE8405731A patent/SE464742B/sv not_active IP Right Cessation
- 1984-11-15 CA CA000467925A patent/CA1238279A/en not_active Expired
- 1984-11-15 IT IT49172/84A patent/IT1178239B/it active
- 1984-11-15 FR FR8417435A patent/FR2555048B1/fr not_active Expired
- 1984-11-16 ES ES537705A patent/ES537705A0/es active Granted
- 1984-11-17 DE DE3442065A patent/DE3442065C2/de not_active Expired - Fee Related
-
1986
- 1986-08-12 US US06/895,806 patent/US4874774A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB2149662A (en) | 1985-06-19 |
| GB2149662B (en) | 1987-06-10 |
| JPS60109519A (ja) | 1985-06-15 |
| DE3442065A1 (de) | 1985-05-30 |
| US4874774A (en) | 1989-10-17 |
| GB8426420D0 (en) | 1984-11-28 |
| IT8449172A0 (it) | 1984-11-15 |
| KR850003501A (ko) | 1985-06-20 |
| ES8600928A1 (es) | 1985-10-16 |
| FR2555048A1 (fr) | 1985-05-24 |
| SE8405731D0 (sv) | 1984-11-15 |
| NL8403310A (nl) | 1985-06-17 |
| KR920001459B1 (ko) | 1992-02-14 |
| CA1238279A (en) | 1988-06-21 |
| DE3442065C2 (de) | 1994-05-05 |
| IT1178239B (it) | 1987-09-09 |
| SE464742B (sv) | 1991-06-10 |
| SE8405731L (sv) | 1985-05-18 |
| IT8449172A1 (it) | 1986-05-15 |
| ES537705A0 (es) | 1985-10-16 |
| JPH048410B2 (enExample) | 1992-02-17 |
| FR2555048B1 (fr) | 1988-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0608207B1 (fr) | Compositions pharmaceutiques contenant des nanocapsules | |
| EP0862423B1 (fr) | Composition pharmaceutique pour administration par voie orale | |
| EP0757911B1 (fr) | Nouvelles formulations galéniques du fénofibrate et leurs applications | |
| CA2102778C (fr) | Nouvelles compositions a base de derives de la classe des taxanes | |
| EP2124961B1 (fr) | Nouvelle composition à base d'oxime de cholest-4-èn-3-one | |
| CH661436A5 (fr) | Compositions de nifedipine administrables par voie rectale et procedes pour leur fabrication. | |
| LU86901A1 (fr) | Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale | |
| EP0927026A1 (fr) | Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques | |
| FR2690847A1 (fr) | Compositions à activité agoniste des récepteurs analogues à 5HT1 sélective. | |
| CH644015A5 (fr) | Solution aqueuse injectable a base d'oxytetracycline. | |
| EP1058540A1 (fr) | Pellet oral a liberation immediate comprenant des glycerides polyglycolyses, procede de fabrication | |
| BE1006829A3 (fr) | Compositions pharmaceutiques solides. | |
| BE1007158A3 (fr) | Composition pharmaceutique a base d'une imidazolylcarbazolone destinee a l'adminstration rectale. | |
| EP0356325B1 (fr) | Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glycéride gélifié par au moins un polymère cellulosique | |
| WO1991015203A1 (fr) | Gelule huileuse de ketoprofene | |
| JPH08169829A (ja) | 血圧降下のための製薬学的組成物及びその製法 | |
| EP0916340A1 (en) | Suppositories | |
| MC1765A1 (fr) | Formes de doses rectales | |
| FR2726470A1 (fr) | Composition a base d'interferon | |
| FR2551755A1 (fr) | Sels de dioxyde de benzothiazine cristallin et compositions pharmaceutiques les contenant | |
| CH622251A5 (enExample) | ||
| WO2000067727A1 (fr) | Formulations galeniques d'agents antithrombiotques pour administration sous-cutanee | |
| FR2803515A1 (fr) | Solution aqueuse stable de deoxyfructosazine | |
| BE684025A (enExample) | ||
| BE561273A (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |